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 Summary
 Background:  The aim of the study was to determine the diagnostic problems encountered in breast diseases, 
their causes as well as the methods of the procedure in such cases.
 Material/Methods:  Clinical and mammographic examinations were conducted in 5445 women aged 35–70 years. 
The patients were divided into 3 groups: group I comprised 4200 patients after screening (aged 
50–69 years), group II – 915 (aged 40–49) and group III – 330 high-risk patients. Additional 
sonomamography was performed in 336 women (8%) in group I, 192 (21%) in group II and on all the 
patients in group III.
  Anamnesis, palpation, mammography (MMG) in 2 projections and magnified X-rays were performed. 
In cases of an unclear image the following procedures were undertaken: sonomammography (USG), 
fine needle aspiration (FNA), mammotomy and surgical biopsy 
  The MMG and USG images were evaluated in BI-RADS scale. The false positive and false negative 
results were established.
 Results: In group I, 228 FNA biopsies (5.4%) were carried out, 55 cancers (1.3%), 32 false positive, 5 false 
negative radiological results were diagnosed. In II group 21 women underwent FNA, false positive 
radiological diagnoses occurred in 14 cases. In group III comprising 60 women who had undergone 
FNA, 18 cancers were observed. These proved false positive diagnosis in 8 cases and false negative 
in 4 cases.
  It was found, that the most common reasons for error were due to dense cysts displaying with 
irregular outlines and microcalcifications accompanying hormonal dysfunction. The displacement 
of tumors near the pectoral muscle or the nipple also interfered with establishing the correct 
diagnosis.
 Conclusions:  The diagnostic problems can be due to the inherent limitations of the methods, the physical 
nature of the breast and localization of the changes. The diagnosis of the benign process should 
be established on the basis of radiological, cytological and histopathological methods. The 
radiologically unclear changes should be diagnosed with the use of FNA/ core biopsy, mammotomy 
or surgical biopsy. In cases of hormonal dysfunctions and during the conservative treatment, 
follow-up after 6 months is suggested. 
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Background
Standard diagnostics of breast diseases is based on clinical 
examination, mammography (MMG) and/or complementary 
ultrasonography (USG), depending on the patient’s age. USG 
is performed in young patients, whereas MMG is recom-
mended for patients over 40, and in high risk group over 
35 years of age [1]. Focal changes are subjected to cytolo-
gical evaluation on fine needle aspiration biopsy (FNA) or 
histopathology based on core needle biopsy, mammotome 
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(MMT), or surgical biopsy [2]. Centers equipped with mag-
netic resonance imaging (MRI) use this method in dubious 
cases, especially when the results of physical examination 
and other diagnostic methods are unclear [3].
All of these methods have specific advantages and limita-
tions, which, in turn, makes the radiologist’s decision very 
important for the further course of the patient.
The aim of the paper was to present the cases which may 
be difficult to diagnose by imaging techniques, to attempt 
the analysis of their causes and to recommend the further 
methods and procedures to be used. 
Materials and methods
In 2005 and during the first 9 months of 2006, 5445 women 
aged 35–70 years, including 4200 entitled to screening for 
breast cancer (50–69 years), and 915 aged 40–49 years 
 taking advantage of a preventive program sponsored by 
the Municipal Administration Office in Szczecin „Healthy 
breasts in 40-year-olds” underwent clinical examination 
and mammography; 330 women were patients treated in 
the Outpatient Department of Genetics of the Pomeranian 
Medical University in Szczecin. Complementary USG 
was performed in the screening group on 336 (8%) cases, 
in the group of 40-year-olds in 192 (21%) and in the risk 
group in all the patients – in half of the cases 6 months 
after MMG. 
Each subject completed before the examination a question-
naire with personal information and anamnesis, according 
to the model form recommended by the National Health 
Fund (NFZ). Palpation examination was carried out by a 
physician, who instructed the patients how to perform self-
examination of the breasts and axillary lymph nodes on 
that occasion Then the women underwent mammography 
in 2 projections, performed according to the commonly 
accepted standards. Targeted images and zoom images with 
pressure applied were obtained for better visualization of 
suspicious lesions.
USG was performed with a linear 7.5–12 MHz head accor-
ding to commonly accepted procedure. USG of the thyroid 
was additionally performed in all women diagnosed with 
benign or malignant breast diseases. 
MMG and USG images were assessed according to BI-RADS 
scale (Breast Imaging Reporting and Data System) [1, 4]. 
The MMG apparatus and image evaluation procedures were 
subject to quality control tests.
USG-guided mammotome biopsies were performed in 22 
patients with BI-RADS 3 and 4 using 11 and 8 G needles. 
MRI was not performed because of lack of the appropriate 
equipment in West Pomerania region. 
In case of USG abnormalities suspicious of pathologic pro-
cess (cysts, solid tumors), FNA was performed, and in those 
of over 5-month duration, mammotome biopsy, and in case 
of lesions invisible under USG – sterotaxic MMG-guided 
wire placement. Additionally, patients with BI-RADS 3 and 
4 microcalcifications invisible under USG were referred 
for MMG-guided mammotome biopsy performed in the 
Regional Oncology Center in Szczecin – the number of such 
procedure was limited for economic reasons. 
The breast structure was assessed on imaging as lipoma-
tous, lipo-adenomatous, adeno-lipomatous, and “dense” 
 adenomatous. Image interpretation was described accor-
ding to the model presented in NFZ forma, and in the 
comments section recommendations concerning accessory 
investigations, further management and active treatment 
were given.
Results
Problems encountered during imaging diagnostics procedu-
res were due to: 
1)  difficulties in carrying out the procedure – small or very 
large breasts, condition after implant surgery
2) dubious interpretation of the image
3)  difficulties in decision-making concerning further diag-
nostic and therapeutic management
Table 1 lists the number of USG examinations and biopsies 
in all three patient groups compared with the number of 
cancer diagnoses. It shows that most USG examinations, 
in proportion to the number of patients, were performed 
in the risk group and in „40-year-olds”, the lowest number 
in the screening group. It was associated with more „dense” 
breast tissue structure in younger women as well as with 
the special „vigilance” in case of Genetics Department 
patients.
Table 2 presents the number of patients as well as the 
false positive and false negative diagnoses in the exami-
ned groups. MMG and USG findings suspicious of cancer 
(BI-RADS 4), which proved to be benign lesions in FNA, 
MMT and surgical biopsy were regarded as false positive, 
and lesions diagnosed as BI-RADS 2 and 3, found on FNA, 
MMT and surgical biopsy to be cancers – as false negati-
ve results. In “difficult to interpret” MMG and USG ima-
ges, adenomatous or lipo-adenomatous breasts with signs 
of mastopathy, distorted architecture and “dense” cysts 
Table 1.  Number of women, sonomammographies, FNA biopsies and breast cancers depending on the examined group.
Group Number of pts Number of USG Number of FNA Number of cancers 
I. 4200 336 (8%) 228 (5.4%) 55 (1.3%)
II. 915 192 (21%) 21 (11%) 0
III. 330 330 (100%) 60 (18%) 18 (5.45%)
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with irregular contours and heterogenous echostructure 
were predominant. Microcalcifications among mastopat-
hic lesions aroused diagnostic doubts, especially if found in 
control MMG images with no previous diagnosis of hormo-
nal dysfunction.
Discussion
The essential task of prophylactic control examinations, 
including screening, is detection of cancer at an early stage. 
The group which benefits most from such examinations are 
premenopausal women, in whom hormonal dyfunctions of 
thyroid and ovaries are the underlying conditions associa-
ted with breast diseases [5]. They may coexist with breast 
cancer and sometimes they can cause it as well.
Mammography is associated with technical problems in 
men, women with very small breasts or very large ones 
which do not fit the 24 x 30 cm tray, or in patients with 
chest deformation [6, 7]. Changes in the ribs and sternum 
may project on mammography film mimicking tumor foci 
located deep close to the thoracic wall (fig.1a, 1b, 1c) or 
some projections may “fail to cover” the whole mamma-
ry gland area. In such cases, the findings may be veri-
fied by palpation and USG. Tumors located peripherally 
(fig. 2), directly on at the borderline with the skin, deep in 
the vicinity of the thoracic wall, may also be difficult to 
visualize [8]. Patients with mastalgia demonstrate guar-
ding against compression applied during mammography, 
which leads to „dense” images causing diagnostic prob-
lems especialaly in adenomatous breasts. Sclerosing ade-
nosis accompanying diseases of the thyroid gland is one 
of such examples (fig. 3a, b, c). Appropriate treatment of 
the thyroid and hyperprolactinemia leads to alleviation of 
painful symptoms and change in breast „density” as well 
as improves the conditions for compression on mammo-
graphy [ 9,10].
Condition after implant mammoplasty also makes it neces-
sary to reduce compression to prevent damage of the pros-
thesis. Thus, the mammary gland is either obscured by 
the implant or the compression of the visualized part is 
too weak. USG is much more useful and easier to perform 
in women after mammoplasty, because the head can be 
applied at various angles (fig. 4) [11].
Table 2.  Histopathological results of malignant tumors in the 
examined groups of patients.
Histopathologic diagnosis Number of pts
Group I Group III 
1. DCIS 14 2
2. CDI 20 4
3. Ca medullare atypicum 5 2
4. Ca lobulare invasivum 12 2
5. Ca in fibroadenoma 2 1
6. Ca tubulo-lobulare 1
7. Tumor cells in FNA 2 6
Total 55 18
Table 3.  Number of false positive and false negative diagnoses in 
the examined groups.
Number of diagnoses
False positive False negativee
Group I 32 (0.76%) 5 (0.12%)
Group II 14 (1.53%) 0
Group III 8 (2.42%) 4 (1.21%)
Note: The percentage was calculated in relation to the number of 
examinations in the particular group.
Figure 1 A.  Mammogramms of both breasts in c-c projection. The shadow 
visible as a tumor at the wall of the thorax on the left side.
Figure 1 B.  Magnified X-ray targeting the suspicious region revealing 
no changes.
Figure 1 C.  Sonomammography image of the left breast – post-rachitic 
changes in the vertebra, breast image normal.
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In young women, cancers are usually due to gene mutations 
and the prognosis is much worse than in older patients 
[12]. They also present many diagnostic problems, because 
lesions seemingly „benign” turn out to be malignant in 40% 
of cases [12]. In our material, we noted such a situation in 
4 patients from the risk group, whose lesions were asses-
sed as benign, whereas on FNA malignant tumor cell sere 
found. On the other hand, lesions suspected to be malig-
nant in 8 women were not diagnosed as such on FNA and 
surgical biopsy; apocrine metaplasia, adenosis sclerosans 
and fibrocystic mastopathy were diagnosed. The lesions 
were dense cystes and mastopathic changes with clusters 
of microcalcifications. As it follows from the studies car-
ried out in cooperation with the department of Genetics 
and Pathomorphology, in women with BRCA1 and 2 gene 
mutations lesions appearing as benign in radiological ima-
ges demonstrate sometimes signs of malignancy in cytolo-
gic smears and histopathologic investigations; correlation 
between the results of radiodiagnostics and histopatholo-
gy is found in ca. 60% of cases (fig. 5). Also the literature 
describes atypical USG and MMG findings in women with 
genetic predispositions for breast and/or ovarian cancer, 
recommending MRI as the most reliable method [13]. For 
this reason, the treatment of all focal lesions in the high 
risk group involves radical surgery.
Similar problems with breast tissue assessment were enco-
untered in the group of women aged 40–49, whose dense, 
adenomatous breasts are often due to hormonal dysfun-
ctions, hormonal treatment, and, as a result, present “atypi-
cal” MMG and USG images [9, 14]. Diagnosis of lesions based 
on MMG only is unreliable; USG, used as a complementary 
diagnostic technique also does not always give unequivocal 
results, especially in women examined for the first time. 
Diagnostic “hypersensitivity” may also be associated 
with more and more demanding attitudes of the patients. 
Un fortu nately, there are only a few centers in Poland which 
can offer free prophylactic programs for women aged 40–49. 
Transferring the responsibility for financing these pro-
cedures to oncologists or gynecologists has considerably 
Figure 2.  Mammography image in c-c projection, malignant mass 
located at the thoracic wall, where only part of the tumor and 
thickened skin are visible.
Figure 3 A.  Bilateral mammography in c-c projection. „Dense” breasts 
with a benign tumor on the left side (sclerosing adenosis).
Figure 3 B.  Sonomammography revealing a pattern of sclerosing 
adenosis. Figure 3 C.  The same patent , USG of the thyroid – a benign tumor.
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limited the availability of these examinations. Even nume-
rous educational programs highlighting this issue will not 
be very helpful, if the attitude to the problem of preven-
tion remains unchanged. We are not surprised that each of 
the examined women wanted to know the nature of her 
disease and not only to be told that her lesion was a benign 
one. If it was a benign lesion, what type was it? Why did it 
develop? Was it a transient disturbance, or a result of other, 
long-term hormonal dysfunction? Eventually, each patient 
diagnosed with one or more focal lesions asked a question 
where she should go next with the problem and which 
spacialist should provide her with further treatment or 
observation – an oncologist-surgeon? gynecologist-endocri-
nologist? or a specialist in thyroid diseases? The patients 
expect to get such recommendations, obviously in addition 
to scheduling the date and type of a control radiological 
examination. 
False negative results obtained in screening concerned 
lesions with rather regular outlines and saturated „dense” 
cysts (BI-RADS 3). These foci were associated with long-
term hormonal therapy, but their „atypical appearance” 
was the basis for additional FNA. Finding tumor cells led to 
Figure 4.  Sonomammography after breast implant surgery – small 
cysts and enlarged milk ducts.
Figure 5.  Sonomammography carried out in a woman from high risk 
group – three small cysts with suspicious microcalcifications 
– DCIS.
Figure 6.  Mammography image in c-c projection. Two cancer foci 
– spicular (arrow) and oval with indistinct outlines (arrow 
head).
Figure 7.  Mammography image of the right breast in oblique projection 
– a tumor with microcalcifications (fibroadenoma) and 
centrally a tumor with visible outlines – ductal carcinoma.
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quick institution of treatment. However, if the patient had 
been scheduled for control examination, the therapy would 
have been considerably delayed [9,10]. 
Interval cancers known in screening practice may represent 
the „calculated risk margin” but such explanation given to a 
patient will be justified neither by the court, nor, which is 
even more obvious, by the woman affected by the disease. 
For this reason, the radiologist must establish as reliable 
diagnosis as possible, based, if necessary, on many different 
diagnostic and therapeutic procedures.
Unequivocal evaluation was also difficult in case of 
postoperative scars with suspicion of relapse, as well as 
radiotherapy-induced and postinflammatory changes 
– in such cases anamnesis was very helpful [7]. In case 
of unpalpable and additionally multifocal changes, meta-
stases from the primary tumors are sometimes impossible 
to diagnose by MMG and USG; coincidence of benign and 
malignant lesions additionally complicates the diagnosis 
[10, 15, 16]. Diagnostic problems are also encountered in 
cases of fatty degeneration, postoperative scars, scars left 
by abscesses and in lactating breasts [7, 17]. Multifocal 
changes present in one breast can be malignant (fig. 6), 
or both benign and malignant (fig. 7), which is not always 
reflected in MMG and USG images.
Caution is required in perimamillar lesions causing 
retraction of the nipple or located close to it. Zoom images 
and additional projections, as well as USG, are very helpful 
in such cases (fig. 8 a, b).
Asymmetrical mastopathic lumps require particular cau-
tion so as not to overlook a malignant process; during the 
first examination their character should be classified and 
recorded in the interpretation to avoid additional projec-
tions or USG during subsequent control examinations 
(fig. 9).
Microcalcifications present as one of the most problem-
atic diagnostic signs, especially if they occur in clusters. 
Microcalcifications disseminated in „dense” adenomatous 
breasts are typical signs of hyperestrogenism, hyperpro-
lactinemia and in 80% of cases – hypothyroidism. Not only 
the diagnosis, but also the decision concerning further 
control examinations can be a problem. Untreated lesions 
(in 50% of cases) demonstrate progression of radiological 
signs. On the basis of our own experience we believe that 
Figure 8 A.  Left breast mammography in oblique projection 
– a retromamillary tumor with outlines difficult to evaluate.
Figure 8 B.  The same patient, zoom mammography, targeted 
on the retromamillary region. A spicular tumor with 
microcalcifications – invasive ductal carcinoma.
Figure 9.  Bilateral mammography in oblique projection. Asymmetric 
mastopathy of the left breast after mastitis.
Figure 10.  Sonomammography showing a dense hypoechoic 
focus with irregular pattern – a cyst in chronic hormonal 
dysfunction.
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control MMG should be performed after a year in order to 
assess microcalcifications, and in case of cyst-like lesions 
or small cysts – control USG 6 months after the commence-
ment of treatment. Also tumors with regular outlines locat-
ed amongst mastopathic lesions seen in MMG, and those 
presenting on USG as hypoechoic, densely saturated foci 
with uneven contours arouse suspicion. Such appearance 
is characteristic e.g. of “old” cysts with irregularly thick-
ened walls, resembling malignant lesions (fig. 10, 11 a, b). 
Typical, dark-green fluid withdrawn from them on FNA 
demonstrated the presence of histiocytes. Histopathological 
investigations revealed in most cases apocrine metapla-
sia, benign dysplasia and fibrocystic mastopathy. In USG 
images, protein particles present in the cyst lumen resem-
ble microcalcifications in appearance (fig. 12), and in case 
of irregular cyst outline require decision concerning fur-
ther management – FNA or observation. A similar decision 
should be made in case of numerous microcalcifications 
visible on MMG performed in women belonging to the high 
risk group and with hormonal dysfunction. 
Diagnostic problems can also be caused by atypical cysts. 
Women (in very rare cases also men) present in oncology, 
Figure 11 B.  Sonomammography of the same patient – hypoechoic 
change with micro-calcifications and central echo.
Figure 12.  Sonomammography – zoom image of the cyst with irregular 
outline with protein molecules resembling microcalcifications 
in appearance.
Figure 13 B.  Sonomammography of the same patient, non-
homogeneous cyst with the foci suspicious of papilloma. 
FNA – thickening of the cyst wall without symptoms 
of hyperplasia.
Figure 13 A.  Mammogram of the left breast – a tumor with regular 
outlines, cyst.
Figure 11 A.  Mammography targeted on the tumor with regular 
outlines but with micro-calcifications – invasive ductal 
carcinoma.
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gynecology and radiology departments, with sudden-onset 
nodules, apin, abscess or mamillary discharge. Atypical 
cysts suspicious of hyperplasia should be investigated by 
biopsy (fig. 13 a, b). After the diagnosis of fibrocystic degen-
eration is established, the radiologist should propose fur-
ther diagnostic management – observation and time of 
control examination, biopsy or cyst resection, collection of 
material for cytology, examination of other organs in case 
of hormonal dysfunction. Further treatment by an oncolo-
gist, gynecologist and/or endocrinologist should also be 
suggested; control USG or MMG 6 months after the com-
mencement of conservative treatment is recommended in 
such cases.
Such management algorithm has proven to work very 
well in our Department of Radiology and in West 
Pomerania region since the start of prevention pro-
grams for women 40–70-years old, sponsored by the 
Regional Health Fund in Szczecin. Since the establish-
ment of the National Health Fund (NFZ), the examination 
have been available only for a limited number of women 
from the screening age group, and family doctors, gyne-
cologists and a few oncologists were unable to cope 
with the demand for radiological diagnostics. We hope 
that introduction of a nationwide screening program 
will not only improve early diagnostics of breast tumors, 
but will also facilitate the diagnostics by subsidies for 
modern equipment and quality assurance systems in 
radiology.
Conclusions
1.  Diagnostic problems in breast diseases can be due to 
inherent limitations of the diagnostic methods used, the 
mammary gland structure and localization of the lesions,
2. T he diagnostic criteria for benign and malignant lesions 
are not always clear, especially in high risk patients,
3.  Hormonal dysfunctions and concurrent malignant lesions 
developing on their background present most diagnostic 
problems,
4.  Diagnosis of a benign breast tumor should be based on 
the results of imaging, cytology, and histopathology, 
especially in the risk group,
5.  Suspicious radiological lesions require verification by a 
biopsy – fine/core needle, mammotome or surgical, and 
in the course of conservative treatment of diagnosed 
hormonal dysfunctions – control imaging examinations 
at 6-month intervals.
